samedan logo
 
 
spacer
home > ict > summer 2010 > several contributors – one document
PAY PER VIEW SERVICE

 

Dear guest!

article: Several Contributors – One Document
format: Adobe Acrobat PDF file
cost: £

spacer

 
News and Press Releases

EUROPEAN CHMP ADOPTS POSITIVE OPINION FOR KITE’S KTE-X19 FOR THE TREATMENT OF RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA

-- If Approved, KTE-X19 will be an Important New Advance for this Disease with a Poor Prognosis -- -- Kite would Become the First Company with Multiple Approved CAR T Therapies in Europe --
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement